Evaluation of similar quality attribute characteristics in SB5 and reference product of adalimumab

Biosimilars are biologic products that are highly similar to a licensed reference product in terms of quality, safety, and efficacy. SB5 is a biosimilar of Humira® (adalimumab) developed by Samsung Bioepis. To demonstrate its biosimilarity in quality to Humira®, we performed a comprehensive characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Nayoung, Lee, JongAh Joanne, Yang, Hahymn, Baek, Serim, Kim, Soohwan, Kim, Sooshin, Lee, Tongkeun, Song, Dami, Park, Gwangmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343792/
https://www.ncbi.nlm.nih.gov/pubmed/30296198
http://dx.doi.org/10.1080/19420862.2018.1530920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343792/
https://www.ncbi.nlm.nih.gov/pubmed/30296198
http://dx.doi.org/10.1080/19420862.2018.1530920

Ejemplares similares